Martin Shkreli, who increased price of lifesaving drug fiftyfold, auctioning off chance to punch him in face

Martin Shkreli, who increased price of lifesaving drug fiftyfold, auctioning off chance to punch him in face
Image via Twitter

Martin Shkreli, the former hedge fund manager vilified in nearly every corner of America for buying a pharmaceutical company and jacking up the price of a life-saving drug more than fiftyfold, says he’s auctioning off a chance to slap/punch him in the face to benefit a former friend.

On his Twitter account, Shkreli says he’ll let someone slap/punch him in the face for a price to help benefit his friend Mike, who recently died and left behind a young son who survived cancer.

To make an auction, a person needs to direct message Shkreli on Twitter.

Shkreli has found himself at the center of a firestorm over drug pricing in the last few months, and he hasn’t been afraid to throw on more fuel.

It began after his company, Turing Pharmaceuticals, spent $55 million in August for the U.S. rights to sell Daraprim, a 62-year-old drug for a rare parasitic infection, and promptly raised the price from $13.50 to $750 per pill.

Continue reading →


Commenting Policy

We have no tolerance for comments containing violence, racism, vulgarity, profanity, all caps, or discourteous behavior. Thank you for partnering with us to maintain a courteous and useful public environment where we can engage in reasonable discourse.

You may use HTML in your comments. Feel free to review the full list of allowed HTML here.